A detailed history of Fifth Third Bancorp transactions in Haemonetics Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 344 shares of HAE stock, worth $25,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares
344
Previous 269 27.88%
Holding current value
$25,232
Previous $21,000 23.81%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

BUY
$71.16 - $93.38 $5,337 - $7,003
75 Added 27.88%
344 $26,000
Q3 2024

Oct 17, 2024

SELL
$72.45 - $91.58 $1,086 - $1,373
-15 Reduced 5.28%
269 $21,000
Q2 2024

Jul 22, 2024

BUY
$81.24 - $97.37 $9,911 - $11,879
122 Added 75.31%
284 $23,000
Q1 2024

Apr 23, 2024

SELL
$71.24 - $85.35 $12,467 - $14,936
-175 Reduced 51.93%
162 $13,000
Q4 2023

Jan 19, 2024

SELL
$80.59 - $92.61 $4,513 - $5,186
-56 Reduced 14.25%
337 $28,000
Q3 2023

Oct 31, 2023

SELL
$82.56 - $93.49 $128,380 - $145,376
-1,555 Reduced 79.83%
393 $35,000
Q2 2023

Jul 25, 2023

BUY
$80.84 - $89.45 $4,203 - $4,651
52 Added 2.74%
1,948 $165,000
Q1 2023

Apr 24, 2023

BUY
$72.75 - $90.6 $2,837 - $3,533
39 Added 2.1%
1,896 $156,000
Q4 2022

Jan 25, 2023

BUY
$73.85 - $86.14 $1,993 - $2,325
27 Added 1.48%
1,857 $0
Q2 2022

Aug 04, 2022

BUY
$49.27 - $66.08 $1,478 - $1,982
30 Added 1.67%
1,830 $119,000
Q1 2022

Apr 19, 2022

SELL
$43.77 - $63.22 $5,777 - $8,345
-132 Reduced 6.83%
1,800 $114,000
Q4 2021

Feb 01, 2022

BUY
$49.55 - $74.59 $47,914 - $72,128
967 Added 100.21%
1,932 $102,000
Q3 2021

Oct 15, 2021

SELL
$57.6 - $70.59 $44,697 - $54,777
-776 Reduced 44.57%
965 $68,000
Q2 2021

Aug 06, 2021

BUY
$51.81 - $118.56 $83,155 - $190,288
1,605 Added 1180.15%
1,741 $116,000
Q1 2021

May 07, 2021

BUY
$111.01 - $139.48 $15,097 - $18,969
136 New
136 $15,000
Q4 2020

Feb 16, 2021

SELL
$88.75 - $119.95 $4,260 - $5,757
-48 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$75.65 - $93.58 $256,604 - $317,423
-3,392 Reduced 98.6%
48 $4,000
Q2 2020

Aug 05, 2020

BUY
$84.96 - $118.91 $37,637 - $52,677
443 Added 14.78%
3,440 $308,000
Q1 2020

May 05, 2020

BUY
$74.34 - $121.82 $201,089 - $329,523
2,705 Added 926.37%
2,997 $299,000
Q2 2019

Aug 07, 2019

SELL
$81.74 - $120.34 $5,476 - $8,062
-67 Reduced 18.66%
292 $35,000
Q4 2018

Feb 14, 2019

SELL
$90.66 - $116.63 $5,802 - $7,464
-64 Reduced 15.13%
359 $36,000
Q3 2018

Nov 14, 2018

SELL
$89.96 - $114.58 $5,037 - $6,416
-56 Reduced 11.69%
423 $48,000
Q1 2018

May 15, 2018

BUY
$60.72 - $74.41 $21,798 - $26,713
359 Added 299.17%
479 $35,000
Q4 2017

Feb 14, 2018

SELL
$44.96 - $58.99 $18,388 - $24,126
-409 Reduced 77.32%
120 $7,000
Q3 2017

Nov 14, 2017

BUY
$40.38 - $44.87 $16,192 - $17,992
401 Added 313.28%
529 $24,000
Q2 2017

Aug 11, 2017

BUY
N/A
128
128 $5,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.76B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.